MarketInOut Stock Screener Log In | Sign Up

Wuhan Healthgen Biotechnology Corp A

SHSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:00
Wuhan Healthgen Biotechnology Corp A stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeSHSE
Market Capitalization12,609 mln
Float38.43 mln

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

49.75
Highly suspicious

Relative Strength

4 / 100
Severely lagging

Debt / Equity

0.13
Very low leverage

Pre-Tax Margin

-343%
Severely loss-making

ROE

-2.20
Negative

Business Description

Founded in 2006 and headquartered in Wuhan, China, Healthgen Biotechnology is a life sciences company that develops and produces proteins used in skincare products, medical research, and drug development. The company specializes in a wide range of laboratory-grown human proteins, including albumin, growth factors, and other biological compounds. It also offers technical services to help clients develop and refine their own protein production and testing processes.

Key Fundamentals

EPS-0.44
ROE-2.20
RPS0.09
ROIC-3.81
ROA-1.68
EBITDA, mln-24.98
EV / EBITDA-515
EV / EBIT-211
Revenue, mln18.27
EV / Revenue704

Quote Details

Last 27.98
Change -1.6 (-5.41%)
Open 28.00
Volume 16,240,475
Turnover 454,408,480
Average Volume 4,289,519

Financial Ratios

Pre-Tax Profit Margin-343
Current Ratio3.00
Price / Book5.01
Price / Tangible Book5.16
Debt / Equity0.13
Price / Sales781

Financial Strength

Altman Z-Score10.52
Piotroski F-Score 7 / 9
Beneish M-Score49.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.38% 7 / 100   
1 Month -27.87% 8 / 100   
2 Months -49.13% 1 / 100   
6 Months -56.14% 1 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog